Advisor Group Holdings »

Cyclacel Pharmaceuticals shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Cyclacel Pharmaceuticals (CYCC) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Cyclacel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Cyclacel Pharmaceuticals held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyclacel Pharmaceuticals by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $123 126 0.98
2024-03-31 $265 126 2.10
2023-12-31 $334 126 2.66

More positions owned by Advisor Group Holdings

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)

View all positions for Advisor Group Holdings

Top funds holding Cyclacel Pharmaceuticals

Armistice Capital
Point72 Asset Management
Acadian Asset Management
Geode Capital Management
Tower Research Capital
McIlrath & Eck
Activest Wealth Management
Advisor Group Holdings
Morgan Stanley
Wells Fargo & Company
Signature
Bank of America Corporation
Harbour Investments
Qube Research & Technologies

View all funds holding Cyclacel Pharmaceuticals